New Study Finds Continuous, Noninvasive Hemoglobin Monitoring Using Masimo SpHb® May Reduce Intraoperative Red Blood Cell Transfusion

IRVINE, Calif.–(BUSINESS WIRE)–Sep. 9, 2016–
Masimo (NASDAQ:
MASI) announced today that in a new study recently presented at the
World Congress of Anesthesiologists (WCA) in Hong Kong, researchers
concluded that continuous and noninvasive hemoglobin monitoring using
Masimo SpHb® may reduce excessive intraoperative red blood
cell (RBC) transfusion.1

In a retrospective review of 371 patients who underwent intraoperative
RBC transfusions between 2012 and 2014 at Fukushima Medical University
in Japan, Dr. Imaizumi and colleagues compared 94 patients who had
noninvasive hemoglobin measurements to 277 patients who did…

Más información: New Study Finds Continuous, Noninvasive Hemoglobin Monitoring Using Masimo SpHb® May Reduce Intraoperative Red Blood Cell Transfusion